ArticleExperimental hematology & oncology2025

Pitavastatin is a novel Mcl-1 inhibitor that overcomes paclitaxel resistance in triple-negative breast cancer.

Dongmi Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.